Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H G Sayer

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Leukemia|December 13, 2003
Efficacy and toxicity of low-dose escalating donor lymphocyte infusion given after reduced intensity conditioning allograft for multiple myelomaF Ayuk, A Shimoni, A Nagler, et al.
Annals of Hematology|December 17, 2002
Filgrastim mobilization and collection of allogeneic blood progenitor cells from adult family donors: first interim report of a prospective German multicenter studyD W Beelen, H Ottinger, K Kolbe, et al.
European Journal of Haematology|August 1, 1988
Bone marrow transplantation for myeloblastomaK Quabeck, D W Beelen, H K Mahmoud, et al.
Die Pharmazie|December 13, 2006
Treatment with granulocyte-colony stimulating factor in patients with acute myocardial infarction. Evidence for a stimulation of neovascularization and improvement of myocardial perfusionF Kuethe, A Krack, M Fritzenwanger, et al.
Deutsche Medizinische Wochenschrift (1946)|March 15, 1991
[Maintenance of remission in acute myeloid leukemia by allogeneic or autologous bone marrow transplantation]D W Beelen, K Quabeck, H K Mahmoud, et al.
Transplantation|September 1, 1990
Six weeks of continuous intravenous cyclosporine and short-course methotrexate as prophylaxis for acute graft-versus-host disease after allogeneic bone marrow transplantationD W Beelen, K Quabeck, B Kaiser, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 1990
Clinical results and the Essen concept of TBIM Molls, U Quast, U W Schaefer, et al.
Annals of Hematology|May 3, 2003
Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemiaN Kröger, M Bornhäuser, G Ehninger, et al.
British Journal of Cancer|September 17, 2002
Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study GroupC Kollmannsberger, O Rick, H Klaproth, et al.
Blood|November 15, 1992
Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantationD W Beelen, E Haralambie, H Brandt, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Leukemia|December 13, 2003
Efficacy and toxicity of low-dose escalating donor lymphocyte infusion given after reduced intensity conditioning allograft for multiple myelomaF Ayuk, A Shimoni, A Nagler, et al.
Annals of Hematology|December 17, 2002
Filgrastim mobilization and collection of allogeneic blood progenitor cells from adult family donors: first interim report of a prospective German multicenter studyD W Beelen, H Ottinger, K Kolbe, et al.
European Journal of Haematology|August 1, 1988
Bone marrow transplantation for myeloblastomaK Quabeck, D W Beelen, H K Mahmoud, et al.
Die Pharmazie|December 13, 2006
Treatment with granulocyte-colony stimulating factor in patients with acute myocardial infarction. Evidence for a stimulation of neovascularization and improvement of myocardial perfusionF Kuethe, A Krack, M Fritzenwanger, et al.
Deutsche Medizinische Wochenschrift (1946)|March 15, 1991
[Maintenance of remission in acute myeloid leukemia by allogeneic or autologous bone marrow transplantation]D W Beelen, K Quabeck, H K Mahmoud, et al.
Transplantation|September 1, 1990
Six weeks of continuous intravenous cyclosporine and short-course methotrexate as prophylaxis for acute graft-versus-host disease after allogeneic bone marrow transplantationD W Beelen, K Quabeck, B Kaiser, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 1990
Clinical results and the Essen concept of TBIM Molls, U Quast, U W Schaefer, et al.
Annals of Hematology|May 3, 2003
Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemiaN Kröger, M Bornhäuser, G Ehninger, et al.
British Journal of Cancer|September 17, 2002
Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study GroupC Kollmannsberger, O Rick, H Klaproth, et al.
Blood|November 15, 1992
Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantationD W Beelen, E Haralambie, H Brandt, et al.
Pageof 5